Leadership & Pay ·
Ocular Therapeutix Chief Strategy Officer Sanjay Nayak resigns effective Oct. 16
OCULOcular Therapeutix, Inc
Sanjay Nayak, M.B.B.S., Ph.D., serving as Chief Strategy Officer of Ocular Therapeutix, Inc., notified the company of his resignation on October 14, 2026. His departure is effective October 16, 2026, to assume the role of Chief Executive Officer at a privately held company. The filing does not disclose details regarding a successor or any changes to existing executive compensation arrangements. Ocular Therapeutix develops and commercializes therapies for diseases of the eye.